• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …

Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

Background Long-term outcomes after percutaneous coronary intervention (PCI) with
contemporary drug-eluting stents, as compared with coronary-artery bypass grafting …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Background: Long-term comparative outcomes after percutaneous coronary intervention
(PCI) with drug-eluting stents and coronary-artery bypass grafting (CABG) for left main …

Diagnostic and therapeutic advances during the past decades have substantially improved
health outcomes for patients with acute coronary syndrome. Both age-related physiological …

The Japanese Circulation Society (JCS) published the “Guidelines for elective percutaneous
coronary intervention [PCI] in patients with stable coronary disease” in 2000. In 2006 …

Abstract The 2017 European Bifurcation Club (EBC) meeting was held in Porto (Portugal)
and allowed a multidisciplinary international faculty to review and discuss the latest data …